Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
- PMID: 11528389
- DOI: 10.1038/ng704
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
Abstract
Myotonic dystrophy type 1 (DM1) is caused by a CTG trinucleotide expansion in the 3' untranslated region of the DM protein kinase gene. People with DM1 have an unusual form of insulin resistance caused by a defect in skeletal muscle. Here we demonstrate that alternative splicing of the insulin receptor (IR) pre-mRNA is aberrantly regulated in DM1 skeletal muscle tissue, resulting in predominant expression of the lower-signaling nonmuscle isoform (IR-A). IR-A also predominates in DM1 skeletal muscle cultures, which exhibit a decreased metabolic response to insulin relative to cultures from normal controls. Steady-state levels of CUG-BP, a regulator of pre-mRNA splicing proposed to mediate some aspects of DM1 pathogenesis, are increased in DM1 skeletal muscle; overexpression of CUG-BP in normal cells induces a switch to IR-A. The CUG-BP protein mediates this switch through an intronic element located upstream of the alternatively spliced exon 11, and specifically binds within this element in vitro. These results support a model in which increased expression of a splicing regulator contributes to insulin resistance in DM1 by affecting IR alternative splicing.
Similar articles
-
Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.Neurology. 2008 Feb 26;70(9):677-85. doi: 10.1212/01.wnl.0000302174.08951.cf. Neurology. 2008. PMID: 18299519
-
Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.Muscle Nerve. 2007 Aug;36(2):251-7. doi: 10.1002/mus.20809. Muscle Nerve. 2007. PMID: 17487865
-
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).Exp Mol Pathol. 2010 Oct;89(2):158-68. doi: 10.1016/j.yexmp.2010.05.007. Epub 2010 Jun 1. Exp Mol Pathol. 2010. PMID: 20685272
-
RNA pathogenesis of the myotonic dystrophies.Neuromuscul Disord. 2005 Jan;15(1):5-16. doi: 10.1016/j.nmd.2004.09.012. Epub 2004 Nov 26. Neuromuscul Disord. 2005. PMID: 15639115 Review.
-
[Pathogenesis of myotonic dystrophy type 1].Gac Med Mex. 2009 Jul-Aug;145(4):331-7. Gac Med Mex. 2009. PMID: 20073433 Review. Spanish.
Cited by
-
Structural and Dynamical Properties of Nucleic Acid Hairpins Implicated in Trinucleotide Repeat Expansion Diseases.Biomolecules. 2024 Oct 10;14(10):1278. doi: 10.3390/biom14101278. Biomolecules. 2024. PMID: 39456210 Free PMC article. Review.
-
Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy.Nat Commun. 2015 May 28;6:7205. doi: 10.1038/ncomms8205. Nat Commun. 2015. PMID: 26018658 Free PMC article.
-
Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood.BMC Med. 2022 Nov 10;20(1):395. doi: 10.1186/s12916-022-02591-y. BMC Med. 2022. PMID: 36352383 Free PMC article. Clinical Trial.
-
RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy.J Biol Chem. 2015 Mar 6;290(10):5979-90. doi: 10.1074/jbc.M114.621607. Epub 2015 Jan 15. J Biol Chem. 2015. PMID: 25593321 Free PMC article.
-
Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.J Neurol. 2013 May;260(5):1245-57. doi: 10.1007/s00415-012-6779-9. Epub 2012 Dec 23. J Neurol. 2013. PMID: 23263591
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials